Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
240 CHF | +1.35% | +0.84% | -8.19% |
26/04 | Roche: positive CHMP opinion for Alecensa | CF |
26/04 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ROG Stock
- RO Stock
- Revisions Roche Holding AG